Kimberly Warren

Chief Business Officer

Kim joined GreenLight in April 2021 from Epizyme Inc. with more than 20 years of business development experience. As the Vice President of Business Development for Epizyme, she was responsible for the negotiation of in-licensing, out-licensing, co-development, and research collaboration agreements. Prior to Epizyme, Kim worked at Sanofi in various business development roles supporting North America commercial operations, oncology R&D, and vaccine R&D, including collaborations in China. Kim also gained international experience in the United Kingdom while leading the business development team at Acambis Inc. She earned her PhD in Medicinal Chemistry from Purdue University and her MBA from Simmons School of Management.